Association of Biotechnology Led Enterprises

News

Glenmark launches anti-diabetes drug Remogliflozin in India

Remogliflozin is a patent-protected sodium glucose co-transporter-2 (SGLT2) inhibitor indicated in treatment of type-2 diabetes mellitus in adults.

May 02, 2019

By : Team ABLE

BCIL transfers ICMR technology-based Shigella Vaccine to Hilleman Labs

The shigella vaccine, developed by NICED-ICMR is expected to have a huge impact by largely benefiting children living in developing countries and in low-income and middle-income settings.

May 02, 2019

By : Team ABLE

US FDA approves first vaccine for prevention of dengue disease in endemic regions

Dengvaxia is the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes. The approval was granted to Sanofi Pasteur.

May 02, 2019

By : Team ABLE

Centre for Promoting Alternatives to Animal Experiments launched by CCMB’s Atal Incubation Centre

The center aims to prioritize investment in human-based, non-animal methodologies in life sciences research in India.

May 02, 2019

By : Team ABLE

Beckman Coulter introduces Total Laboratory Automation Solution setting new standard for turnaround time

The DxA 5000 delivers rapid and consistent turnaround time, providing the industry's most comprehensive pre-analytical sample quality assessment and improves laboratory efficiency.

May 02, 2019

By : Team ABLE